Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3; study content and details appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-12T21:33:07.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior warning about funding/status (Revision: v3.4.1) as administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T01:40:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now includes a government funding status notice and a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:23:16.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The changes are minor UI and wording updates (Show glossary, capitalization tweaks in QC-related labels, and revision/version indicators) that do not modify study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T07:28:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 entry.
    Difference
    0.0%
    Check dated 2026-01-14T03:27:58.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure text and the previous Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:15:31.000Z thumbnail image

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.